This preview shows page 1. Sign up to view the full content.
Unformatted text preview: Module 1 --- Article 6 TREATMENT HIGHLIGHTS NIGHT EATING SYNDROME Night eating syndrome is found to be common among psychiatric outpatients. This study, conducted at 2 outpatient psychiatric clinics, was designed to determine the prevalence of night eating syndrome and coexisting psychopathology among psychiatric patients. Night eating syndrome was diagnosed if at least 1 of the following 2 criteria was met: (1) evening hyperphagia (intake of more than one-third of total daily calories after the evening meal) or (2) nighttime awakening at least 3 times per week, with ingestion of food. Coexisting psychiatric diagnoses and medications were determined via chart review. Night eating syndrome was diagnosed in 12.3% of the total sample (49 of 399 patients).1 Patients with night eating syndrome were more likely than those without night eating syndrome (a) to have an active or remitted substance use disorder (30.6% vs 8.3%) and (b) to be prescribed atypical antipsychotics (38.8% vs 30.8%). Patients with night eating syndrome had, on average, a higher body mass index (BMI) than patients without the syndrome (BMI of 33.1 vs 27.7). Compared to patients with normal weight, those who were overweight were 2.5 times more likely to have night eating syndrome, and those who were obese were 5.2 times more likely. The authors cite research associating treatment with sertraline2 with a reduction in night eating syndrome symptoms. The authors conclude that “night eating syndrome is a prevalent disorder among psychiatric outpatients and is associated with substance use, atypical antipsychotic use, and obesity. Treatment is available to manage this syndrome.”
1 399 patients were administered the Night Eating Questionnaire. 205 of the 399 patients scored at least 20 (out of a possible score of 56) and were selected to participate in a semistructured telephone interview. 121 of the patients were available for the interview. Night eating syndrome was diagnosed in 12.3% of the initial group (49 of 399) or in 15.6% of the initial group minus those unavailable for the interview (49 of 315). Generic name (Trade name): sertraline (Zoloft) 2 Lundgren JD, Allison KC, Crow S, et al. Prevalence of the night eating syndrome in a psychiatric population. American Journal of Psychiatry, 163: 156-158, 2006. Support: National Institute of Mental Health; National Institute of Diabetes and Digestive and Kidney Diseases. ©Copyright 2011 MWK Publishing LLC; from The Complete Practitioner: Mental Health Applications (Vol. 9, No. 3 -- March 2006) For next article, go to next page. ...
View Full Document
This note was uploaded on 02/10/2011 for the course PCO 4930 taught by Professor Neimeyer during the Spring '09 term at University of Florida.
- Spring '09